Browsing by Author Schmoll, Hans-Joachim

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2012Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialClarke, Stephen; Cartwright, Thomas; Cunningham, David; De Gramont, A.; et al, Various; Hecht, J; Im, Seock-Ah; Moore, Malcolm; Rivera, Fernando; Schmoll, Hans-Joachim; Tabernero, Josep; Van Cutsem, E; Concord Clinical School: MedicineBevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial, Lancet Oncology, vol.13, 12, 2012,pp 1225-1233
2016Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trialClarke, Stephen; Cunningham, David; et al, Various; Kim, Sunyoung; Kim, Tae; Kim, Taeyou; Park, Youngsuk; Roh, Jae; Schmoll, Hans-Joachim; Sclafani, Francesco; Tabernero, Josep; Northern Clinical School: Kolling InstituteDalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial, International Journal of Cancer, vol.140, 2, 2016,pp 431-439
2016Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trialClarke, Stephen; Cunningham, David; et al, Various; Kim, Sunyoung; Kim, Tae; Kim, Taeyou; Park, Youngsuk; Roh, Jae; Schmoll, Hans-Joachim; Sclafani, Francesco; Tabernero, Josep; Northern Clinical School: Kolling InstituteDalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial, International Journal of Cancer, vol.140, 2, 2016,pp 431-439
2016MRI rectal cancer in Australia and New Zealand: An audit from the PETACC-6 trialWilson, Kate; Coscia, Claudio; Gormly, Kirsten; Harvey, Jennifer A; Price, Timothy; Schmoll, Hans-Joachim; Tebbutt, Niall; Wells, Tim; NH&MRC Clinical Trials CentreMRI rectal cancer in Australia and New Zealand: An audit from the PETACC-6 trial, Journal of Medical Imaging and Radiation Oncology, vol.60, 5, 2016,pp 607-615
2016MRI rectal cancer in Australia and New Zealand: An audit from the PETACC-6 trialWilson, Kate; Coscia, Claudio; Gormly, Kirsten; Harvey, Jennifer A; Price, Timothy; Schmoll, Hans-Joachim; Tebbutt, Niall; Wells, Tim; NH&MRC Clinical Trials CentreMRI rectal cancer in Australia and New Zealand: An audit from the PETACC-6 trial, Journal of Medical Imaging and Radiation Oncology, vol.60, 5, 2016,pp 607-615